Innovation
3 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace slowing. Cited 66 times.
| Year | Filings |
|---|---|
| 2023 | 2 |
| 2024 | 1 |
Investor mix
5 investors on record; lead investors include FRIBA Investment, Skyviews Life Science, Team Europe, Paulig.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 1 | 20% |
| Angel & family office | 1 | 20% |
| Other / undisclosed | 3 | 60% |